US EditionImmunotherapy helps certain cancer patients avoid surgery: ‘We hope this is the future’
- In 2020, Kelly Spill was diagnosed at age 28 with stage III rectal cancer in the United States and faced a standard treatment plan involving chemotherapy, radiation, and invasive surgery.
- Before beginning chemotherapy, Spill was offered the chance to take part in a clinical trial that treated her cancer exclusively with the immunotherapy agent dostarlimab, which activates the body's immune response against tumors lacking proper mismatch repair and is gentler than conventional therapies.
- The new study included 117 patients with mismatch repair-deficient cancers, and after six months, 80% who completed dostarlimab treatment avoided surgery, radiation, or chemotherapy with minimal toxicity.
- Spill received 30-minute infusions every three weeks without adverse side effects, her tumor disappeared after nine treatments, and she has since carried additional children, preserving her fertility.
- This immunotherapy trial shows promise in reducing invasive treatments for select patients with certain genetic mutations but requires larger studies to confirm long-term benefits and wider applicability.
14 Articles
14 Articles
Immunotherapy helps certain cancer patients avoid surgery, other invasive treatments: ‘We hope this is the future’
A new study found that the immunotherapy treatment worked against some types of cancers, allowing patients to avoid surgery and other types of more invasive treatment to cure their disease.
Wiener Privatklinik hosts free oncology event in Bucharest featuring leading experts from Vienna - Business Review
Wiener Privatklinik, one of Austria’s largest private hospitals and a five-time recipient of the “World’s Best Hospital” distinction, will host a free patient-focused oncology event on May 13, 2025, starting at 10:00 AM at Hotel Marmorosch, Bucharest. The event, titled “State-of-the-Art Cancer Treatments”, brings together six internationally renowned cancer specialists from Vienna who will share […] The post Wiener Privatklinik hosts free oncolo…
Vietnamese patients testing US cancer drug show positive signs
Three months after Tam Anh General Hospital System launched the VISTA-1 study on oral immunotherapy drugs for cancer treatment, the first 8 patients with late-stage colorectal cancer were treated according to the protocol, with no significant side effects initially recorded and good signs.
Immunotherapy helps some patients with cancer to avoid surgery; understand
Kelly Spill did not cry when she was diagnosed with lung cancer in stage III at 28 years of age. She kept her emotions under control when she said that she could not be able to have another baby — radiation treatment could significantly affect fertility — and that she could need to use a colostoma bag to collect her body waste after surgery. “I didn’t cry at any of those moments”, said Spill, who was recently new and had given the light a few mo…
Coverage Details
Bias Distribution
- 75% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
